Is the Dexamethasone-Sparing Strategy Ready For Cisplatin? Too Early For an Answer

J Clin Oncol. 2018 Sep 10;36(26):2741-2742. doi: 10.1200/JCO.2018.78.8109. Epub 2018 May 25.

Authors

Luigi Celio¹, Erminio Bonizzoni¹, Matti Aapro¹

Affiliation

¹ Luigi Celio, Fondazione IRCCS "Istituto Nazionale dei Tumori," Milan, Italy; Erminio Bonizzoni, University of Milan, Milan, Italy; and Matti Aapro, Genolier Cancer Center, Genolier, Switzerland.

PMID: 29799771
DOI: 10.1200/JCO.2018.78.8109

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents*
Cisplatin*
Dexamethasone
Humans
Neurokinin-1 Receptor Antagonists
Palonosetron
Vomiting

Substances

Antineoplastic Agents
Neurokinin-1 Receptor Antagonists
Palonosetron
Dexamethasone
Cisplatin